Brief: Century Therapeutics Reports Full Year 2022 Financial Results
16/03/2023 11:45
March 16 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS REPORTS FULL YEAR 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATES
* CENTURY THERAPEUTICS INC - ENDED 2022 WITH CASH, CASH
EQUIVALENTS, AND INVESTMENTS OF $367.4 MILLION; CASH RUNWAY
EXPECTED INTO 2026
* CENTURY THERAPEUTICS INC - EXPECTS FULL YEAR GAAP
OPERATING
EXPENSES TO BE BETWEEN $135 MILLION AND $145 MILLION
Source text for Eikon: ID:nGNX7KRVqd
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview